INBP · Integrated Biopharma Inc · Insider Trading

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.

Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Includes 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 138,667 owned by the Reporting Person directly.

Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 14,709 shares of Common Stock owned by the Estate of Carl DeSantis.

Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,242,809 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 14,709 shares of Common Stock owned by the Estate of Carl DeSantis.

Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust, 14,709 shares of Common Stock owned by the Estate of Carl DeSantis and 138,667 owned by the Reporting Person directly.

Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,242,809 shares of Common Stock owned by the Carl DeSantis Revocable Trust, 14,709 shares of Common Stock owned by the Estate of Carl DeSantis and 138,667 owned by the Reporting Person directly.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026.

50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.

75% of the options became exercisable on June 2, 2015 with 25% becoming exercisable in twelve (12) equal monthly installments beginning on July 2, 2015.

135,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.

144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.

75% of the options became exercisable on June 2, 2015 with 25% becoming exercisable in twelve (12) equal monthly installments beginning on July 2, 2015.

72,500 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.

81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.

175,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.

144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.

81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025.

55,555 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.

55,555 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.

65,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025.

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024.

The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024.